Incidence of New Asthma and Asthma Exacerbation Pre‐ and Post‐ COVID ‐19 Pandemic in the United States

Ryan Lee; Darren L. Yang; Roham Hadidchi; Montek Singh Boparai; Sonya Henry; Tim Q. Duong

doi:10.1111/cea.70321

April 21, 2026Clinical & Experimental Allergy

Incidence of New Asthma and Asthma Exacerbation Pre‐ and Post‐ COVID ‐19 Pandemic in the United States

View at Publisher

Ask AI

Bookmark

Share

Key Points

The research aims to analyze the incidence of new asthma cases and exacerbations during and after the COVID-19 pandemic.
Comparative analysis of asthma incidence before and after the COVID-19 pandemic.
Assessment of asthma exacerbation rates in children and adults.
Overall asthma incidence and exacerbations decreased during the pandemic.
Asthma rates in children returned to baseline levels by 2024.
Asthma rates in adults remained lower than pre-pandemic levels.

Implication

Analysis reports changes in asthma rates among children and adults pre- and post-pandemic, indicating varying impacts.

Abstract

Summary Overall asthma incidence and exacerbations fell during COVID‐19 and remained below pre‐pandemic levels by 2024. Post‐pandemic asthma rates rebounded to baseline in children but remained suppressed in adults.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lee et al. (2026) studied this question.

synapsesocial.com/papers/69eb092b553a5433e34b3ba5 https://doi.org/10.1111/cea.70321

View at Publisher

Ask AI

Bookmark

Share

Incidence of New Asthma and Asthma Exacerbation Pre‐ and Post‐ COVID ‐19 Pandemic in the United States

Key Points

Implication

Abstract

Discussion

Cite This Study

Incidence of New Asthma and Asthma Exacerbation Pre‐ and Post‐ COVID ‐19 Pandemic in the United States

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

More related papers

More from Clinical & Experimental Allergy

Keep reading

More related papers

More from Clinical & Experimental Allergy